Search Results for: cancer stem cells

Word Cloud of Every CIRM-funded grant yields some surprising insights

CIRM-word-cloud

CIRM, the California stem cell agency, has funded hundreds of grants during its relatively short existence. You can do searches of these grants through a handy dandy web portal that CIRM has made available–it’s a very cool tool and I commend CIRM for making it available. I wish the tool had more options however including […]

Word Cloud of Every CIRM-funded grant yields some surprising insights Read More »

Podcasts

Podcast for Week of July 5 Topics –Stem Cell Tourism in the U.S. –CIRM –Article in the Hill by stem cell opponent –Stem cell hype on aging   Podcast for Week of July 11 Topics: –two papers on stem cell-based tissue engineering and one on stem cell treatments for heart disease, –the Republican candidates for

Podcasts Read More »

From genes to chemicals: iPS cell field, reprogramming in transition

FaviconIPSCELL

Sheng Ding’s lab reports today in Cell Stem Cell (you can read it here) that they have replaced all genetic factors in a new iPS cell reprogramming method except Oct4. The other factors were replaced by chemical compounds. Thus, we continue a major transition in the iPS cell field away from genes and toward chemicals.

From genes to chemicals: iPS cell field, reprogramming in transition Read More »

Tumorigenicity and Pluripotency teased apart? Not yet for Myc

Fig.-5-Nakagawa-et-al.-Myc-in-cancer-and-IPScs

A paper just came out in PNAS entitled “Promotion of direct reprogramming by transformation-deficient Myc“. The main thrust of this paper is that the tumorigenic and pluripotency-related functions of Myc could be separated. It focused primarily on the lesser studied LMyc. The topic of the intertwined good (pluripotency) and bad (tumorigenicity) functions of Myc, addressed

Tumorigenicity and Pluripotency teased apart? Not yet for Myc Read More »